Vgenomics, Meril Genomics Partner to Transform Precision Medicine in India

Meril Genomics, a reputable diagnostics and molecular biology provider, and Vgenomics, a leading precision health firm, have announced a ground-breaking collaboration to supply hospitals and research facilities across India with complementing advanced genomic diagnostics. Through this strategic partnership, Meril Genomics' demonstrated skills in molecular biology and diagnostics are combined with Vgenomics' proficiency in bioinformatics, AI-driven research, and translational genomics.

It will broaden the reach of precision medicine and mark a major milestone in genomic healthcare in India. Non-Invasive Prenatal Testing (NIPT) is an endeavor under this collaboration, which meets the increasing risk of most of the chromosomal defects like Down syndrome among the mothers above advanced maternal age. NIPT would help ensure early diagnosis, eventually contributing to safer pregnancies and healthier outcomes for newborns in India.

The unique feature of the partnership is that it brings in specialized Next Generation Sequencing targeted to TB. This will provide great access to the healthcare scenario in India where about 26% of the Global TB cases are reported every year. It would enable quick and accurate detection, thus allowing timely treatment and management of the disease at the national level.

The program also uses Whole Exome Sequencing (WES) to diagnose rare diseases, which will help almost 70 million people in India who are afflicted. By combining WES with cutting-edge AI analytics, rare disease patients will experience shorter diagnostic wait times, more individualized treatment plans, and a shorter diagnostic trip overall.

“Together, we envision an India where every citizen has seamless access to advanced genomic diagnostics and precision medicine,” stated Dr. Rahila Sardar, CEO, Vgenomics. “Our partnership with Meril Genomics exemplifies our mutual dedication to leveraging genomic science to achieve groundbreaking improvements in patient care and medical outcomes.”